Table 1.

Baseline characteristics of the included patients

CharacteristicFresher (N = 12 308)Older (N = 20 651)
Age, y 68 (56-78) 68 (56-78) 
Male sex, n (%) 6270 (50.9) 10 389 (50.3) 
In ICU at randomization, n (%) 6842 (55.6) 10 021 (48.5) 
Patients undergoing surgery, n (%) 3691/7632 (48.4) 5771/11 144 (51.8) 
Cardiothoracic surgery, n (%) 1337/7637 (17.5) 2195/11 150 (19.7) 
ABO group, n (%)   
4952 (40.2) 8285/20 650 (40.1) 
AB 470 (3.8) 790/20 650 (3.8) 
1462 (11.9) 2483/20 650 (12.0) 
5424 (44.1) 9092/20 650 (44.0) 
Coexisting disorders, n (%)   
Cardiovascular disease 1945/7634 (25.5) 3349/11 142 (30.1) 
Myocardial infarction 368/4090 (9.0) 379/4123 (9.2) 
Heart failure 1658/5242 (31.6) 3059/8747 (35.0) 
Diabetes 1348/5242 (25.7) 2202/8747 (25.2) 
Stroke 102/5242 (1.9) 102/8747 (1.2) 
Hemoglobin level at randomization, g/dL 7.6 (7.0-8.6) 7.6 (7.0-8.6) 
Mechanical ventilation at randomization, n (%) 3528/7636 (46.2) 4722/11 150 (42.3) 
Renal replacement therapy at randomization, n (%) 665/7635 (8.7) 760/11 150 (6.8) 
Vasopressor at randomization, n (%) 1954/4082 (47.9) 2019/4125 (48.9) 
CharacteristicFresher (N = 12 308)Older (N = 20 651)
Age, y 68 (56-78) 68 (56-78) 
Male sex, n (%) 6270 (50.9) 10 389 (50.3) 
In ICU at randomization, n (%) 6842 (55.6) 10 021 (48.5) 
Patients undergoing surgery, n (%) 3691/7632 (48.4) 5771/11 144 (51.8) 
Cardiothoracic surgery, n (%) 1337/7637 (17.5) 2195/11 150 (19.7) 
ABO group, n (%)   
4952 (40.2) 8285/20 650 (40.1) 
AB 470 (3.8) 790/20 650 (3.8) 
1462 (11.9) 2483/20 650 (12.0) 
5424 (44.1) 9092/20 650 (44.0) 
Coexisting disorders, n (%)   
Cardiovascular disease 1945/7634 (25.5) 3349/11 142 (30.1) 
Myocardial infarction 368/4090 (9.0) 379/4123 (9.2) 
Heart failure 1658/5242 (31.6) 3059/8747 (35.0) 
Diabetes 1348/5242 (25.7) 2202/8747 (25.2) 
Stroke 102/5242 (1.9) 102/8747 (1.2) 
Hemoglobin level at randomization, g/dL 7.6 (7.0-8.6) 7.6 (7.0-8.6) 
Mechanical ventilation at randomization, n (%) 3528/7636 (46.2) 4722/11 150 (42.3) 
Renal replacement therapy at randomization, n (%) 665/7635 (8.7) 760/11 150 (6.8) 
Vasopressor at randomization, n (%) 1954/4082 (47.9) 2019/4125 (48.9) 

Data are median (quartile 25th–quartile 75th) or n/N (%).

ICU, intensive care unit.

or Create an Account

Close Modal
Close Modal